mhurhangee/patent-ind-claim-en huggingface dataset:
A composition comprising: an aqueous phase including at least one water-soluble UV sunscreen filter at a concentration by weight of from 2% to 25%, based upon weight of the composition; and an oil phase consisting of: dimethicone, at a concentration by weight of from 1% to 25%, based upon weight of the composition; an emulsifying crosslinked siloxane elastomer at a concentration, by weight, of 0.1% to 20%, based upon weight of the composition; and optionally, a co-emulsifier at a concentration, by weight, of 0.01% to 1%, based upon weight of the composition; wherein a ratio, by weight, of the aqueous phase to the oil phase is 5.0 to 9.0; and wherein the composition converts from an emulsion to a plurality of droplets upon application of shear. an aqueous phase including at least one water-soluble UV sunscreen filter at a concentration by weight of from 2% to 25%, based upon weight of the composition; and an oil phase consisting of: dimethicone, at a concentration by weight of from 1% to 25%, based upon weight of the composition; an emulsifying crosslinked siloxane elastomer at a concentration, by weight, of 0.1% to 20%, based upon weight of the composition; and optionally, a co-emulsifier at a concentration, by weight, of 0.01% to 1%, based upon weight of the composition; wherein a ratio, by weight, of the aqueous phase to the oil phase is 5.0 to 9.0; and wherein the composition converts from an emulsion to a plurality of droplets upon application of shear. dimethicone, at a concentration by weight of from 1% to 25%, based upon weight of the composition; an emulsifying crosslinked siloxane elastomer at a concentration, by weight, of 0.1% to 20%, based upon weight of the composition; and optionally, a co-emulsifier at a concentration, by weight, of 0.01% to 1%, based upon weight of the composition; wherein a ratio, by weight, of the aqueous phase to the oil phase is 5.0 to 9.0; and wherein the composition converts from an emulsion to a plurality of droplets upon application of shear.
An arrangement for positioning a patient's body and tracking the patient's position during surgery comprising: - a body shape capturing device adapted to acquire an outer contour shape (S) of at least a part of the patient's body ; - a processing unit adapted to generate based on the patient body's shape (S) a data representation (M) for a patient receiving device adapted to at least partially receiving the patient's body ; - a 3D shape generating device adapted to additively manufacture based on the data representation (M) at least parts of the patient receiving device comprising at least one tracker element that is connected to the patient receiving device and adapted to indicate the position and orientation of the patient receiving device ; characterized by further comprising: - a medical imaging system adapted to acquire at least one at least two-dimensional medical image of the patient's region of interest in relation to the at least one tracker element in a preoperative scan; - a localization system at the operation site for capturing data indicating the at least one tracker element's position during surgery; - a live imaging device for acquiring live images of the surgical site; and - a computation unit adapted to register and blend the medical and live images according to the captured data of the tracker element's position during surgery. - a body shape capturing device adapted to acquire an outer contour shape (S) of at least a part of the patient's body ; - a processing unit adapted to generate based on the patient body's shape (S) a data representation (M) for a patient receiving device adapted to at least partially receiving the patient's body ; - a 3D shape generating device adapted to additively manufacture based on the data representation (M) at least parts of the patient receiving device comprising at least one tracker element that is connected to the patient receiving device and adapted to indicate the position and orientation of the patient receiving device ; - a medical imaging system adapted to acquire at least one at least two-dimensional medical image of the patient's region of interest in relation to the at least one tracker element in a preoperative scan; - a localization system at the operation site for capturing data indicating the at least one tracker element's position during surgery; - a live imaging device for acquiring live images of the surgical site; and - a computation unit adapted to register and blend the medical and live images according to the captured data of the tracker element's position during surgery.
A display method for an electronic device with a flexible display , wherein physical forms of the flexible display comprise an expanded state and a non-expanded state, when the flexible display is in the non-expanded state, the flexible display is divided into a main screen and a secondary screen , and the method comprises: when the flexible display is in a black screen state, detecting, by the electronic device , an expansion action performed by a user on the flexible display ; and lighting, by the electronic device , the entire flexible display in response to the expansion action; displaying, by the electronic device , content on a first screen of the flexible display , wherein the first screen is the main screen or the secondary screen ; detecting, by the electronic device , a preset touch operation performed on the flexible display , wherein an action point of the preset touch operation is located on a second screen, and when the first screen is the main screen , the second screen is the secondary screen , or when the first screen is the secondary screen , the second screen is the main screen ; and if the flexible display is in the expanded state, displaying, by the electronic device on the entire flexible display in response to the preset touch operation, the content displayed on the first screen; or if the flexible display is in the non-expanded state, displaying, by the electronic device on the second screen in response to the preset touch operation, the content displayed on the first screen, wherein the content is synchronously displayed on the first screen and the second screen for a period of time before the first screen is turned off. when the flexible display is in a black screen state, detecting, by the electronic device , an expansion action performed by a user on the flexible display ; and lighting, by the electronic device , the entire flexible display in response to the expansion action; displaying, by the electronic device , content on a first screen of the flexible display , wherein the first screen is the main screen or the secondary screen ; detecting, by the electronic device , a preset touch operation performed on the flexible display , wherein an action point of the preset touch operation is located on a second screen, and when the first screen is the main screen , the second screen is the secondary screen , or when the first screen is the secondary screen , the second screen is the main screen ; and if the flexible display is in the expanded state, displaying, by the electronic device on the entire flexible display in response to the preset touch operation, the content displayed on the first screen; or if the flexible display is in the non-expanded state, displaying, by the electronic device on the second screen in response to the preset touch operation, the content displayed on the first screen, wherein the content is synchronously displayed on the first screen and the second screen for a period of time before the first screen is turned off.
A computer method comprising: directing a code module of a source code management (SCM) system to be transferred to a product lifecycle management (PLM) system in a user request, the user request including supporting data corresponding to the code module extracted from the SCM system , the extracted supporting data representing one or more of hierarchical relationships of other code modules, supporting code modules, and tracking information; creating a PLM system module having the extracted data representing the code module, the hierarchical relationships of other code modules, the supporting code modules, and the tracking information; responsive to an update request , comparing a version of the created PLM system module to a version of the linked module of the SCM system by accessing the tracking information, wherein the tracking information is stored on the SCM system and has a link to the created module of the PLM system , the SCM system thereby retaining a link to the created module; and if the module of the SCM system is a newer version, updating the PLM system module to the newer version of the module of the SCM system . directing a code module of a source code management (SCM) system to be transferred to a product lifecycle management (PLM) system in a user request, the user request including supporting data corresponding to the code module extracted from the SCM system , the extracted supporting data representing one or more of hierarchical relationships of other code modules, supporting code modules, and tracking information; creating a PLM system module having the extracted data representing the code module, the hierarchical relationships of other code modules, the supporting code modules, and the tracking information; responsive to an update request , comparing a version of the created PLM system module to a version of the linked module of the SCM system by accessing the tracking information, wherein the tracking information is stored on the SCM system and has a link to the created module of the PLM system , the SCM system thereby retaining a link to the created module; and if the module of the SCM system is a newer version, updating the PLM system module to the newer version of the module of the SCM system .
An effective amount of an anti-Gall antibody for use in a method for modulating angiogenesis in a cancer refractory to anti-VEGF, said method comprising: (a) identifying a cancer cell as refractory to anti-VEGF; and (b) contacting the refractory cancer cell with the effective amount of an anti-Gal1 antibody to thereby modulate angiogenesis in the refractory cancer cell. (a) identifying a cancer cell as refractory to anti-VEGF; and (b) contacting the refractory cancer cell with the effective amount of an anti-Gal1 antibody to thereby modulate angiogenesis in the refractory cancer cell.
A method of diagnosing a domesticated cat for obesity or a predisposition to obesity comprising the steps of: a. determining from a fecal sample obtained from the cat if the cat has one or more of: i. a gut population of one or more bacterial species selected from Megasphaera elsdenii, Megamonas rupellensis, Megamonas funiformis, Megamonas hypermegale, and Bacteroides coprophilus at a level below a pre-determined threshold for the selected bacterial species; and/or ii. a gut population of one or more bacterial species selected from Lactobacillus reuteri and Blautia schinkii at a level above a pre-determined threshold for the selected bacterial species; and thereby diagnosing the domesticated cat for obesity or a predisposition to obesity. a. determining from a fecal sample obtained from the cat if the cat has one or more of: i. a gut population of one or more bacterial species selected from Megasphaera elsdenii, Megamonas rupellensis, Megamonas funiformis, Megamonas hypermegale, and Bacteroides coprophilus at a level below a pre-determined threshold for the selected bacterial species; and/or ii. a gut population of one or more bacterial species selected from Lactobacillus reuteri and Blautia schinkii at a level above a pre-determined threshold for the selected bacterial species; and i. a gut population of one or more bacterial species selected from Megasphaera elsdenii, Megamonas rupellensis, Megamonas funiformis, Megamonas hypermegale, and Bacteroides coprophilus at a level below a pre-determined threshold for the selected bacterial species; and/or ii. a gut population of one or more bacterial species selected from Lactobacillus reuteri and Blautia schinkii at a level above a pre-determined threshold for the selected bacterial species; and
A medical image analysis method of unmixing color channels from a multi-channel image of a biological tissue sample stained with a plurality of stains, said method comprising: a. obtaining the multi-channel image comprising the plurality of stains, wherein a strength or intensity of the color channel of each stain varies depending on a local focus quality, wherein the focus quality is determined by computing a metric for each image pixel, wherein a threshold or a set of thresholds is applied to the metric, wherein the plurality of region images comprises a first region image comprising pixels that are classified as in focus and a second region image comprising pixels that are classified as out of focus; b. classifying the multi-channel image into a plurality of regions based on the local focus quality; c. splitting the multi-channel image into a plurality of region images corresponding to the regions; d. for each region image, determining a plurality of reference vectors corresponding to the color channels for that local focus quality, wherein each reference vector comprises a red, a green, and a blue color component associated with each color channel; e. unmixing each region image using the reference vectors determined for the region image, wherein unmixing each region image results in a plurality of individual stain channel images; and f. combining the individual stain channel images of the region image into a combined stain channel image for each stain channel, thereby producing a plurality of combined stain channel images. a. obtaining the multi-channel image comprising the plurality of stains, wherein a strength or intensity of the color channel of each stain varies depending on a local focus quality, wherein the focus quality is determined by computing a metric for each image pixel, wherein a threshold or a set of thresholds is applied to the metric, wherein the plurality of region images comprises a first region image comprising pixels that are classified as in focus and a second region image comprising pixels that are classified as out of focus; b. classifying the multi-channel image into a plurality of regions based on the local focus quality; c. splitting the multi-channel image into a plurality of region images corresponding to the regions; d. for each region image, determining a plurality of reference vectors corresponding to the color channels for that local focus quality, wherein each reference vector comprises a red, a green, and a blue color component associated with each color channel; e. unmixing each region image using the reference vectors determined for the region image, wherein unmixing each region image results in a plurality of individual stain channel images; and f. combining the individual stain channel images of the region image into a combined stain channel image for each stain channel, thereby producing a plurality of combined stain channel images.
A liquid blow molding device comprising a cylindrical nozzle to be inserted into a mouth part of a synthetic resin-made preform , and configured to supply a pressurized liquid (L) into the preform through the nozzle to blow mold the preform into a liquid-containing container of a predetermined shape, characterized in that the nozzle has, at a lower end thereof, a seal surface that, when the nozzle is inserted into the mouth part , abuts on a step surface provided at an inner circumferential surface of the preform in an axial direction to seal a gap between the nozzle and the inner circumferential surface of the preform , and the step surface is tapered to be higher on a radial inner side than on a radial outer side.
An optical assembly of an endoscope comprising an objective tube and at least one optical element held in the objective tube , wherein the objective tube comprises at least one region functioning as a clamping mount for the optical element , wherein this region of the objective tube functioning as a clamping mount is manufactured at least sectionally from a shape-memory material, wherein a memory effect of the shape-memory material from a deformed shape to a trained shape occurs when a memory temperature is exceeded and the trained shape of the objective tube is selected in that there is a clamping mount between the optical element to be held and the region of the objective tube functioning as a clamping mount, wherein at least one first optical element and one second optical element are available, wherein the first optical element is held in a first region of the objective tube functioning as a clamping mount for the first optical element and the second optical element is held in a second region of the objective tube functioning as a clamping mount for the second optical element , wherein the objective tube comprises a deformable transition region between the first region and the second region , which is easier deformable than the neighboring adjacent first and second regions of the objective tube and wherein the first region has a first cross-section and the second region has a second cross-section different therefrom, wherein the first and the second cross-section are different in size and shape and wherein the deformable transition region creates a transition from the first cross-section to the second cross-section between the first and second region and wherein at least one spring element is provided as the transition region .
A method for purifying steviol glycosides, comprising the steps of: (a) providing an aqueous or aqueous alcoholic solution comprising steviol glycosides; (b) providing a plurality of consecutively connected columns packed with an adsorbent resin capable of adsorbing steviol glycosides to create a multi-column system; (c) passing the solution of steviol glycosides through the multi-column system wherein different steviol glycosides are retained in different sections of the multi-column system at different concentrations, depending on the affinities to the sorbent; (d) removing impurities by washing the multi-column system with water; and (e) eluting the adsorbed steviol glycosides from at least one column in the multi-column system with an aqueous alcohol solution having a water to alcohol ratio ranging from about 60:40 to about 0.1:99.9, to obtain an eluted solution comprising steviol glycosides. (a) providing an aqueous or aqueous alcoholic solution comprising steviol glycosides; (b) providing a plurality of consecutively connected columns packed with an adsorbent resin capable of adsorbing steviol glycosides to create a multi-column system; (c) passing the solution of steviol glycosides through the multi-column system wherein different steviol glycosides are retained in different sections of the multi-column system at different concentrations, depending on the affinities to the sorbent; (d) removing impurities by washing the multi-column system with water; and (e) eluting the adsorbed steviol glycosides from at least one column in the multi-column system with an aqueous alcohol solution having a water to alcohol ratio ranging from about 60:40 to about 0.1:99.9, to obtain an eluted solution comprising steviol glycosides.
A methylotrophic Pichia yeast cell comprising: a) a first recombinant nucleic acid molecule comprising an exogenous nucleic acid encoding a Mxr1 transcriptional activator operably linked to at least one alcohol oxidase 1 (AOX1) promoter element; and b) a second recombinant nucleic acid molecule comprising a nucleic acid encoding a member of the globin family PF00042 operably linked to at least one AOX1 element; and c) a recombinant molecule comprising a nucleic acid encoding at least one polypeptide involved in the biosynthesis of heme selected from the group consisting of ALA synthase, ALA dehydratase, porphobilinogen deaminase, UPG III synthase, UPG III decarboxylase, CPG oxidase, PPG oxidase, and ferrochelatase, operably linked to a least one methanol-inducible promoter element. a) a first recombinant nucleic acid molecule comprising an exogenous nucleic acid encoding a Mxr1 transcriptional activator operably linked to at least one alcohol oxidase 1 (AOX1) promoter element; and b) a second recombinant nucleic acid molecule comprising a nucleic acid encoding a member of the globin family PF00042 operably linked to at least one AOX1 element; and c) a recombinant molecule comprising a nucleic acid encoding at least one polypeptide involved in the biosynthesis of heme selected from the group consisting of ALA synthase, ALA dehydratase, porphobilinogen deaminase, UPG III synthase, UPG III decarboxylase, CPG oxidase, PPG oxidase, and ferrochelatase, operably linked to a least one methanol-inducible promoter element.
An inflatable medical device comprising: a balloon having a balloon length and comprising a constant-diameter section disposed between proximal and distal tapered sections arranged longitudinally along a longitudinal axis of the device; the balloon comprising a balloon wall comprising a first layer , wherein the first layer comprises first and second longitudinal reinforcement fibers having fiber lengths less than about 75% of the balloon length ; and the first and the second reinforcement fibers are arranged such that they overlap in a reinforcement fiber overlap area . a balloon having a balloon length and comprising a constant-diameter section disposed between proximal and distal tapered sections arranged longitudinally along a longitudinal axis of the device; the balloon comprising a balloon wall comprising a first layer , wherein the first layer comprises first and second longitudinal reinforcement fibers having fiber lengths less than about 75% of the balloon length ; and the first and the second reinforcement fibers are arranged such that they overlap in a reinforcement fiber overlap area .
A recombinant expression vector for expressing a target protein in mitochondria in a mammal cell, comprising a promoter sequence exhibiting a transcriptional activity in a cell nucleus in the mammal cell, and a coding region encoding the target protein under control of the promoter sequence, wherein the coding region contains one or more TGAs as a codon corresponding to tryptophan, and wherein the promotor sequence exhibits an ability to induce transcription of an mRNA encoding the target protein in a cell nucleus of a mammal, provided the promoter is not T7 promoter.
A resin bond abrasive article comprising a plurality of alumina abrasive particles retained in a binder material, wherein the alumina abrasive particles have an outer surface with an adhesion-modifying layer covalently bound thereto, wherein the adhesion-modifying layer comprises a reaction product of an epoxy-functional coupling agent and hydroxyl groups covalently bound to the outer surface of the abrasive particle, wherein the epoxy-functional coupling agent comprises a reaction product of: a polyepoxide; and an aminosilane represented by the formula HNR 1 R 2 wherein: R 1 represents -Z-SiL 3 ; R 2 represents -Z-SiL 3 ; each Z independently represents a divalent linking group having from 1 to 6 carbon atoms; and each L independently represents a hydrolyzable group. a polyepoxide; and an aminosilane represented by the formula HNR 1 R 2 wherein: R 1 represents -Z-SiL 3 ; R 2 represents -Z-SiL 3 ; each Z independently represents a divalent linking group having from 1 to 6 carbon atoms; and each L independently represents a hydrolyzable group. R 1 represents -Z-SiL 3 ; R 2 represents -Z-SiL 3 ; each Z independently represents a divalent linking group having from 1 to 6 carbon atoms; and each L independently represents a hydrolyzable group.